alexa
Reach Us +1-947-333-4405

GET THE APP

Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
The Global Incidence And Prevalence Of Multiple Myeloma Over The Next 10 Years (2017-2027) | 91469
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 1300

Journal of Clinical & Experimental Pathology received 1300 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

The global incidence and prevalence of multiple myeloma over the next 10 years (2017-2027)

Joint Event on 15th EUROPEAN PATHOLOGY CONGRESS & 14th International Conference on LEUKEMIA AND HEMATOLOGIC ONCOLOGY

Atul Sharma and Nishant Kumar

Decision Resources Group, India

ScientificTracks Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681-C1-045

Abstract
Objective: The objective of this study was to estimate the global incidence and prevalence of multiple myeloma by region over the next 10 years using a multi-factorial forecast model. Methods: Using a critically appraised set of country-specific cancer registries, multiple myeloma incidences were estimated for 45 countries, representing approximately 90% of the world population in 2017. Observed correlations between GDP, multiple myeloma risk, and survival were used to trend multiple myeloma incidence over the next 10 years. Multiple Myeloma survival was trended using an attenuated function of historical trends and factoring in the anticipated uptake of newer, more efficacious treatment regimens in the future. Prevalence was estimated as a cumulative incidence over preceding 20 years with adjustments for disease-specific and competing-cause mortality for each year. To estimate incident and prevalent multiple myeloma globally, aggregate estimates for each region were divided by the proportion of countries in that region for which direct estimates were made using the methods described above. The incident cases were also reported by the symptomatic status, as treatment guidelines are based this, thus are important to initiate treatment for a patient. Results: The incidence of multiple myeloma in Africa, Latin America, lower-income Asia Pacific countries, high-income Asia Pacific countries, Europe, and North America is 1, 2, 2, 5, 7 and 8 cases per 100,000/year. The prevalence of multiple myeloma in Africa, Latin America, lower-income Asia Pacific countries, high-income Asia Pacific countries, Europe, and North America is 4, 8, 7, 19, 25, and 32 cases per 100,000. Lower-Income Asia Pacific is expected to see the highest growth in prevalent cases over the next ten years: 71% by 2027. Conclusion: The incidence and prevalence of multiple myeloma is expected to increase globally. Improvements in the survival of multiple myeloma patients and ageing of population of will result in 325 thousand additional cases surviving by 2027 worldwide.
Biography

Atul Sharma is an Associate Epidemiologist in the Epidemiology team at Decision Resources Group with an expertise in Cancer Epidemiology. He has a Bachelor’s degree in Dental Surgery from Himachal Pradesh University, India and a Master’s degree in Public Health from PGIMER, India. He specializes in developing epidemiological forecasts for the multiple indications within the DRG syndicated portfolio. His field of interest lies in the oncology.

E-mail: [email protected]

Top